期刊
JOURNAL OF PHYSIOLOGICAL SCIENCES
卷 62, 期 3, 页码 163-172出版社
SPRINGER JAPAN KK
DOI: 10.1007/s12576-012-0196-9
关键词
Hypoxic pulmonary hypertension; 15-Lipoxygenase; 15-Hydroxyeicosatetraenoic acid; Vasoconstriction; Remodeling
类别
资金
- National Natural Science Foundation of China [30370578, 30470752, 31071007]
- Science Foundation of Education Department of Heilongjiang Provence [11531181, 11551275]
- Science Foundation of Health Department of Heilongjiang Provence [2009-250, 2009-251]
Pulmonary arterial hypertension (PAH) is a rare disease with a complex aetiology characterized by elevated pulmonary artery resistance, which leads to right heart ventricular afterload and ultimately progressing to right ventricular failure and often death. In addition to other factors, metabolites of arachidonic acid cascade play an important role in the pulmonary vasculature, and disruption of signaling pathways of arachidonic acid plays a central role in the pathogenesis of PAH. 15-Lipoxygenase (15-LO) is upregulated in pulmonary artery endothelial cells and smooth muscle cells of PAH patients, and its metabolite 15-hydroxyeicosatetraenoic acid (15-HETE) in particular seems to play a central role in the contractile machinery, and in the initiation and propagation of cell proliferation via its effects on signal pathways, mitogens, and cell cycle components. Here, we focus on our important research into the role played by 15-LO/15-HETE, which promotes a proliferative, antiapoptotic, and vasoconstrictive physiological milieu leading to hypoxic pulmonary hypertension.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据